Article: Ribavarin and stavudine safe in patients coinfected with hepatitis C virus.

2003 JUL 7 - (NewsRx.com & NewsRx.net) -- Ribavarin and stavudine can be safely combined in HIV/hepatitis C patients, although their efficacy is questionable.

According to published research from France, "a randomized, open-label trial was performed to study virological and intracellular interactions between stavudine and ribavirin in 30 patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV)."

"Patients were randomized to receive either interferon and ribavirin or no treatment for HCV infection for three months," and "intracellular peripheral blood mononuclear cells' stavudine-triphosphate (TP) concentrations were ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!